0001062993-13-004735.txt : 20130919
0001062993-13-004735.hdr.sgml : 20130919
20130919190724
ACCESSION NUMBER: 0001062993-13-004735
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130917
FILED AS OF DATE: 20130919
DATE AS OF CHANGE: 20130919
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOULD GEORGE M
CENTRAL INDEX KEY: 0001242115
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 131106419
MAIL ADDRESS:
STREET 1: C/O PROTINE DESIGN LAB
STREET 2: 34801 CAMPUS DR
CITY: FREEMONT
STATE: CA
ZIP: 94555
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2013-09-17
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001242115
GOULD GEORGE M
287 TILLOU ROAD
SOUTH ORANGE
NJ
07079
1
0
0
0
Stock Option (Right to Buy)
17.91
2013-09-17
4
A
0
15000
0
A
2023-09-17
Common Stock
15000
15000
D
The options were granted on September 17, 2013 and will vest in four equal annual installments beginning on the first anniversary of the grant date.
/s/ George Gould by Carl A. Valenstein, attorney in fact
2013-09-19